Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension.

Clinical pharmacology and therapeutics - 1 Dec 2006

Iaccarino Guido, Izzo Raffaele, Trimarco Valentina, Cipolletta Ersilia, Lanni Francesca, Sorriento Daniela, Iovino Gianni Luigi, Rozza Francesco, De Luca Nicola, Priante Ornella, Di Renzo Gianfranco, Trimarco Bruno

Abstract excerpt

OBJECTIVES: Although blood pressure is considered the major determinant of left ventricular hypertrophy in hypertension, genetic variability is increasingly being considered among the factors influencing this complication. beta(2)-Adrenergic receptors (beta(2)ARs) are up-regulated in hypertension...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antihypertensive Agents
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heterozygote

Share to Hypertension

Share to Hypertrophy, Left Ventricular

Share to Polymorphism, Genetic

Share to Receptors, Adrenergic, beta-2

Share to Signal Transduction

Source

Identifiers

PMID: 17178264
DOI: 10.1016/j.clpt.2006.09.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17178264-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension.PMID 17178264Read ↗

The Glu27 allele of the beta2 adrenergic receptor increases the risk of cardiac hypertrophy in hypertension.Semantic proximity Read ↗

beta(2)-Adrenergic receptor polymorphisms and determinants of cardiovascular risk: the Cardiovascular Health Study.Semantic proximity Read ↗

Association of beta 1-adrenergic receptor gene polymorphisms with left ventricular hypertrophy in human essential hypertension.Semantic proximity Read ↗

Beta1- and beta2-adrenoceptor polymorphisms and cardiovascular diseases.Semantic proximity Read ↗

Beta(2)-adrenergic receptor gene polymorphism, age, and cardiovascular phenotypes.Semantic proximity Read ↗

The Arg16Gly polymorphism of the beta2-adrenergic receptor and left ventricular systolic function.Semantic proximity Read ↗

Genetic variation in angiotensin II type 2 receptor gene influences extent of left ventricular hypertrophy in hypertrophic cardiomyopathy independent of blood pressure.Semantic proximity Read ↗

Mechanisms of pharmacogenomic effects of genetic variation within the cardiac adrenergic network in heart failure.Semantic proximity Read ↗

A Single Nucleotide Polymorphism near the CYP17A1 Gene Is Associated with Left Ventricular Mass in Hypertensive Patients under Pharmacotherapy.Semantic proximity Read ↗

Beta2-adrenoceptor gene polymorphisms.Semantic proximity Read ↗

Pharmacogenomics of β-adrenergic receptor physiology and response to β-blockade.Semantic proximity Read ↗

The Arg16Gly-β(2)-adrenoceptor single nucleotide polymorphism: exercise capacity and survival in patients with end-stage heart failure.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.